Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 70710-1531

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 70710-1531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 01)

HCI stands for Human-Computer Interaction, which is the study of designing, evaluating, and implementing interactive computing systems for human use and with consideration of the human perspective. It is an interdisciplinary field that combines knowledge and methodologies from computer science, psychology, design, anthropology, and other related disciplines with the goal of improving the usability, accessibility, and overall user experience in the interaction between humans and computers.*

FDA Label Image

Image (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 02)

FDA Label Image

Image (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 03)

The given text is a chemical formula with the molecular structure of a compound. The compound has a complex structure with three variations of chemical bonds, including C-O, C-N, and P-O. The compound also contains carbon, hydrogen, oxygen, nitrogen, and/or phosphorus atoms. The values of m and n are either 14 or 16.*

FDA Label Image

Image (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 04)

The text appears to be describing a type of coating called MPEG-DSPE coating which is applied to an aqueous core that contains doxorubicin HCI. The coated substance seems to have a liposomal bilayer structure.*

FDA Label Image

10 mL Container Label (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 05)

This is a description of a sterile injectable medication called DOXOrubicin Hydrochloride Liposome Injection. The medication is a cytotoxic agent, intended for intravenous infusion only. It comes in a 10mL single-dose vial and has a usual dosage, which can be found in the package insert. It is important to discard any unused portions and keep the vial refrigerated between 2 to 8°C (36 to 46°F) but not frozen. The medication is manufactured by Cadia Healthcare Limited in Ahmedabad, India, and is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

FDA Label Image

10 mL Carton Label (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 06)

DOXOrubicin Hydrochloride Liposome Injection is a medication that may be used to treat certain types of cancer. Not available for further information due to limited text.*

FDA Label Image

25 mL Container Label (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 07)

This is a medication called DOXOrubicin Hydrochloride, which is a cytotoric agent used for intravenous infusion only. It comes in a sterile liposome injection format, with a usual dosage of 2mg/mL that must be diluted before use. The medication should be refrigerated at 2 to 8°C (36 to 46°F) and discarded after use. The manufacturer is not available, but it is distributed by Zydus Pharmaceuticals (USA) Inc. The package contains a 25mL single-dose vial, and it should not be frozen.*

FDA Label Image

25 mL Carton Label (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 08)

FDA Label Image

Image (B3a11bdd 2b24 4d5a 9c35 0df1ee8807c3 144 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.